Astria Therapeutics, Inc.
ATXSDelisted Jan 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001454789
Astria Therapeutics, Inc. was delisted on Jan 23, 2026; its insiders filed their last Form 4 on Jan 23, 2026; 141 institutions reported holding it in 13F filings for Q4 2025, worth $738.2M in total; Soros Fund Management was the only superinvestor holding it.
Q1 2022 vs. Q4 2021
How the institutions holding Astria Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 33 | 33 | 0 |
| Shares | 6.09M | 6.21M | +116.9K (+1.9%) |
| Value | $32.8M | $41.7M | +$8.83M (+26.9%) |
New holders (6)
Institutions that held Astria Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FMR LLC | 353,884 | $2.38M | 0.00% |
| Susquehanna International Group, LLP | 18,530 | $124.0K | 0.00% |
| Corton Capital Inc. | 11,597 | $78.0K | 0.03% |
| Schonfeld Strategic Advisors LLC | 11,500 | $77.0K | 0.00% |
| Simplex Trading, LLC | 1,335 | $8.00K | 0.00% |
| SOA Wealth Advisors, LLC. | 7 | $0 | 0.00% |
Sold out (6)
Institutions that held Astria Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Renaissance Technologies LLC | 34,361 | $185.0K |
| Wolverine Trading, LLC | 12,836 | $65.0K |
| Old Well Partners, LLC | 12,116 | $65.0K |
| Millennium Management LLC | 10,259 | $55.0K |
| UBS Group AG | 3,247 | $18.0K |
| Federated Hermes, Inc. | 64 | $1.00K |